Cargando…
Utilization and short-term outcomes of percutaneous left atrial appendage occlusion in patients with cancer
BACKGROUND: Percutaneous left atrial appendage occlusion (LAAO) has been rapidly evolving since FDA’s approval in 2015 and has become more of a same-day-discharge procedure. Cancer patient with atrial fibrillation/flutter (AF) population can benefit from the procedure but the in-hospital outcomes an...
Autores principales: | Zhang, Yaqi, Yang, Zhuoran, Almani, Muhammad U., Soon-Shiong, Raquel, Liu, Bolun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625234/ https://www.ncbi.nlm.nih.gov/pubmed/37924143 http://dx.doi.org/10.1186/s40959-023-00192-z |
Ejemplares similares
-
Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
por: Wang, Xiaoyan, et al.
Publicado: (2021) -
Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
por: Ding, Wern Yew, et al.
Publicado: (2020) -
Left Atrial Appendage Occlusion
por: Mirdamadi, Ahmad, et al.
Publicado: (2013) -
Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update
por: De Backer, O, et al.
Publicado: (2014) -
Percutaneous interventions in elderly patients with atrial fibrillation: left atrial ablation and left atrial appendage occlusion
por: Mikhaylov, Evgeny N, et al.
Publicado: (2017)